Plawker M W, Fleisher J M, Nitti V W, Macchia R J
Department of Urology, State University of New York Health Science Center at Brooklyn, USA.
J Urol. 1996 Feb;155(2):601-4. doi: 10.1016/s0022-5347(01)66462-0.
We analyzed practice and referral patterns of primary care practitioners regarding the diagnosis of prostate cancer, and the evaluation and treatment of voiding dysfunction.
An anonymous multiple-choice questionnaire was mailed to all primary care practitioners in Brooklyn, New York who were registered with the Medical Society of the State of New York.
More than 25% of primary care practitioners begin performing digital rectal examination after patient age 55 years. Compared to prostate specific antigen (PSA) 59% of practitioners believe that digital rectal examination is more sensitive or that the tests are equal, or they do not know. In regard to PSA 11% of respondents begin testing after patient age 60 years, 11% evaluate PSA only if digital rectal examination is abnormal and greater than 3% never evaluate PSA. Approximately 45% of primary care practitioners indicated that PSA of greater than 4.0 ng./ml. signifies prostate cancer regardless of patient age, prostate size or prostatis and 50% think that digital rectal examination elevates PSA in a clinically significant way. Although 93.2% of respondents refer a patient to a urologist after palpating a prostatic nodule, only 51.1% refer for an area of induration. Of the 47.2% of respondents who attempt pharmacotherapy for voiding dysfunction with finasteride, terazosin or both 15% do not know the agent mechanisms of action. Of those prescribing finasteride 68.6% are not aware of its effects on serum PSA. Overall 66.5% of primary care practitioners are not familiar with the American Urological Association Symptom Index while only 15% of those attempting pharmacotherapy use the index as a diagnostic tool.
Primary care practitioners might require further education in regard to the use of PSA, digital rectal examination and pharmacotherapy in voiding dysfunction. Consideration should be given to the establishment of guidelines for urological referral.
我们分析了初级保健医生在前列腺癌诊断以及排尿功能障碍评估和治疗方面的实践及转诊模式。
向纽约州医学协会注册的纽约布鲁克林所有初级保健医生邮寄了一份匿名多项选择题问卷。
超过25%的初级保健医生在患者55岁之后才开始进行直肠指检。与前列腺特异性抗原(PSA)相比,59%的医生认为直肠指检更敏感,或者两种检查效果相同,或者他们不清楚。关于PSA,11%的受访者在患者60岁之后才开始检测,11%仅在直肠指检异常时才评估PSA,超过3%的医生从不评估PSA。约45%的初级保健医生表示,无论患者年龄、前列腺大小或前列腺炎情况如何,PSA大于4.0 ng/ml即意味着前列腺癌,50%的医生认为直肠指检会以具有临床意义的方式升高PSA。尽管93.2%的受访者在触及前列腺结节后会将患者转诊给泌尿科医生,但只有51.1%会因硬结区域转诊。在尝试用非那雄胺、特拉唑嗪或两者联合进行药物治疗排尿功能障碍的47.2%受访者中,15%不知道药物的作用机制。在开非那雄胺处方的医生中,68.6%不知道其对血清PSA的影响。总体而言,66.5%的初级保健医生不熟悉美国泌尿外科学会症状指数,而在尝试药物治疗的医生中,只有15%将该指数用作诊断工具。
初级保健医生在PSA、直肠指检的使用以及排尿功能障碍的药物治疗方面可能需要进一步培训。应考虑制定泌尿科转诊指南。